Hippokratia 2017, 21(3):147-149
Delides A1, Panayiotides JG2, Kaberos A3, Giotakis I1
12nd Otolaryngology Department, “Attikon” University Hospital, 22nd Department of Pathology, “Attikon” University Hospital, School of Medicine, National & Kapodistrian University of Athens, 3Otolaryngology Department, “Jannio” Hospital of Peireaus, Athens, Greece
Background: Proteus Syndrome (PS) is a rare hamartoneoplastic disorder consisting of a disproportionate and asymmetric overgrowth of body parts, leading to severe body and face disfigurement. Individuals with PS frequently need to undergo a number of surgical procedures including Otolaryngology interventions. Their peculiar anatomy turns even the most straightforward intervention to a challenging one.
Case description: A 31-year-old adult male with PS presented with recurrent epistaxis and nasal obstruction.A nasal mass was found during the physical examination, which was surgically removed under general anesthesia. Histology revealed juvenile angiofibroma.
Conclusion: This is the first reported case of a patient with PS presenting with juvenile nasopharyngeal angiofibroma. Although vascular malformations may appear in these patients, juvenile nasopharyngeal angiofibroma should be taken under consideration when PS patients present with recurrent epistaxis. HIPPOKRATIA 2017, 21(3): 147-149.
Key words: Hamartoma syndrome, multiple, Proteus syndrome, angiofibroma, nasal neoplasm, nasopharyngeal neoplasm
Corresponding author: Alexander Delides MD,PhD, 2nd Otolaryngology Department, National & Kapodistrian University of Athens, School of Medicine, “Attikon” University Hospital, 1 Rimini st., Chaidari, 124 62, Athens, Greece, tel:+306944769769, fax: +302105831393, e-mail: email@example.com
Juvenile nasopharyngeal angiofibroma (JNA) is a benign, slowly growing, locally aggressive vasoformative neoplasm. It is a relatively rare and sporadic tumor and represents approximately 0.5 % of all head and neck tumors1.
Proteus syndrome is a complex hamartoneoplastic disorder consisting of a disproportionate and asymmetric overgrowth of body parts, malformations of venous and lymphatic capillaries, and abnormal growth regulation of the adipose tissue2. Cohen and Heyden first described it in 19793, but only in 1983 Rudolf Wiedemann, named it Proteus syndrome (PS) after the Greek sea-God, who could assume many forms to escape capture4. Individuals with PS that are represented by the literature hero “The Elephant Man”, frequently need to undergo several surgical procedures including Otolaryngology interventions.
The syndrome affects the head and neck area with asymmetrical overgrowth of the cranium or the facial skeleton, disfiguration of the auricle and the nose and alterations of the anatomy of internal structures such as the nasal and paranasal cavities, the ear, and the larynx. Surprisingly, patients even though severely disfigured, often remain functional for many years and can breathe and swallow normally retaining an acceptable quality of life5.
The present case, a 31-year-old male, represents the only living patient with PS in Greece, who was referred to our Department with one month history of nasal obstruction and epistaxis during the preceding two weeks. His past medical history was significant for PS. He appeared to be normal at birth but gradually developed the characteristic abnormalities of the syndrome (Figure 1). He was diagnosed with PS at the age of 18 months. He had already been submitted to several surgical procedures before the age of 16 including amputation of the right leg, tonsillectomy, removal of a testicle epithelioma, and mastoidectomy with drainage of a brain abscess.
Figure 1: The appearance of the patient A) preoperatively, with a hemorrhagic nasal mass visible in his right nostril, B) during his 5th year of age appearing almost normal with some disfigurement noted in his right facial skeleton. C) The appearance of his right auricle and D) of his left hand with hypertrophy of the paramedian finger.
Physical examination revealed macrocephaly, significant right hemimandibular hyperplasia and deviated chin, bossing of the skull in the right frontal area, right facial hemihypertrophy, mandibular prognathism, depressed nasal dorsum, gingival hyperplasia, hypoplastic, haphazardly arranged teeth, reduced tongue mobility, and an open mouth at rest. His auricles appeared severely hypertrophic as did his paramedian hand fingers (Figure 1). He was mentally disabled, but some communication could be achieved with voice responses.
During his clinical examination, a mass was found to obstruct the right nasal cavity completely, protruding into the nasopharynx. Computed tomography and magnetic resonance imaging scans showed the severely altered anatomy, but the mass was noted to occupy the right nasal cavity with benign radiographic characteristics (Figure 2). According to his mother, his nasal obstruction was severely affecting his normal sleep and swallowing functions.
Figure 2: T2-weighted magnetic resonance axial head image showing a mass occupying the right nasopharynx (short arrow) and the right maxillary sinus (long arrow) occupied by retention of mucus. The sinus is smaller than the contralateral and nasal passages are rotated to the left
It was decided to treat the patient surgically and, after written informed consent, he underwent surgery under general anesthesia, administered after fiberoptic-guided intubation. The mass was removed under endoscopic guidance using cold instruments. Anatomical landmarks were severely altered. The inferior and middle turbinates were recognized, but additional surgical steps such as a middle meatal antrostomy or an ethmoidectomy were avoided. An attachment of the polypoid mass was noted to the posterior end of the middle turbinate, and was transected and coagulated with bipolar coagulation. Packing was placed and the patient recovered uneventfully. Histology of the specimen demonstrated irregular fibrous stroma with large and smaller vessels, typical of an angiofibroma (Figure 3).
Figure 3: Histology section showing the irregular fibrous stroma (long arrow) with large (short arrow) and smaller vessels, typical of angiofibroma (Hematoxylin & Eosin stain, x10).
During the three postoperative days, recurrent episodes of self-limited epistaxis occurred. The packing was removed on the fourth day. The patient had to be transfused with three units of blood, due to a total drop of 4 g/dl of his hemoglobin. He was discharged on the 10th postoperative day and the histologic examination revealed the tumor to be JNA. Two years later, his mother reports that he is free of symptoms, but no nasal examination has been performed to exclude a possible recurrence or residual disease.
This is the first reported case of JNA in a patient with PS. JNA is the most common benign neoplasm of the nasopharynx, seen almost exclusively in prepubescent males6. It has rarely been reported in older adults or females such as a rare case of nasopharyngeal angiofibroma in an elderly female7.
Removal of JNA is challenging and may be performed endoscopically or in combination with open procedures. Since these tumors are highly vascular with tendency of profuse intraoperative bleeding, preoperative embolization is recommended6. Diagnosis is based on the radiologic appearance of the mass and its location; it usually originates from the sphenopalatine foramen. A biopsy is not recommended due to its vascularity. Radiologic diagnosis in the reported case was inconclusive regarding the site of origin of the tumor, due to alterations of the anatomy. The age of the patient was not suggestive of JNA. Nevertheless, the delayed seek for medical advice due to the comorbidities of his PS could be an explanation. A preoperative angiography/ embolization was thus not performed.
PS has a global incidence estimated to be less than one in a million. Recently researchers have identified that the cause of PS is a somatic mosaic mutation of the AKT1 oncogene kinase8, an enzyme involved in cell proliferation. Vascular malformations are prevalent in these patients9, but JNA is not regarded as such. Otolaryngological surgical interventions are frequently needed, and these procedures are challenging due to the severely altered anatomy. They are predominately performed to improve the patient’s quality of life since the prognosis is unpredictable.
Given the histology of the tumor, we regard that with the performed procedure, a possibility of residual disease exists. Nevertheless, no radiologic follow-up has been performed, and the patient remains free of symptoms.
Conflict of interest
The authors have no conflict of interest or financial disclosures.
1. Jacobsson M, Petruson B, Svendsen P, Berthelsen B. Juvenile nasopharyngeal angiofibroma: a report of eight cases. Acta Otolaryngol. 1988; 105: 132-139.
2. Cohen MM Jr. Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet. 2014; 85: 111-119.
3. Cohen MM Jr, Hayden PW. A newly recognized hamartomatous syndrome. Birth Defects Orig Artic Ser. 1979; 15: 291-296.
4. Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg E. The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible ac-celerated growth and visceral affections. Eur J Pediatr. 1983; 140: 5-12.
5. Angurana SK, Angurana RS, Panigrahi I, Marwaha RK. Proteus syndrome: clinical profile of six patients and review of literature. Indian J Hum Genet. 2013; 19: 202-206.
6. Yiotakis I, Eleftheriadou A, Davilis D, Giotakis E, Ferekidou E, Korres S, et al. Juvenile nasopharyngeal angiofibroma stages I and II: a comparative study of surgical approaches. Int J Pediatr Otorhinolaryngol. 2008; 72: 793-800.
7. Szymańska A, Korobowicz E, Gołabek W. A rare case of nasopharyngeal angiofibroma in an elderly female. Eur Arch Otorhinolaryngol. 2006; 263: 657-660.
8. Yang Z, Xu Z, Sun YJ, Ma L. Heterozygous somatic activating AKT1 mutation in a case of Proteus syndrome with mental retardation. J Dermatol. 2014; 41: 188-189.
9. Popescu MD, Burnei G, Draghici L, Draghici I. Proteus Syndrome: a difficult diagnosis and management plan. J Med Life. 2014; 7: 563-566.